Ozanezumab Usage And Synthesis

Uses

Ozanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research[1].

References

[1] Meininger V, et al. Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017 Mar;16(3):208-216. DOI:10.1016/S1474-4422(16)30399-4

Ozanezumab(1310680-64-8)Related Product Information

• Mosunetuzumab
• Otelixizumab
• catumaxomab
• Inebilizumab
• rafivirumab
• Aprutumab
• Ublituximab
• Ligelizumab
• Enokizumab
• VeltuzuMab